News
Why choose MSK to treat your child’s germ cell or sex cord stromal tumors The importance of diagnosing tumors as cancer or benign Germ cell tumors and sex cord stromal tumors can be malignant (cancer) ...
Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease PRESS RELEASE GlobeNewswire Dec. 19, 2024, 08:00 AM ...
The Lupus Foundation of America (LFA) is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in Systemic Lupus Erythematosus) study was officially completed on February 21, 2025 ...
Bone marrow aspirate concentrate (BMAC) and adipose-derived stromal vascular fraction (ADSVF) are the most marketed stem cell therapies to treat a variety of conditions in the general population ...
Various immune and stromal cell subsets formed multicellular communities, or collections of cell states, present in the tumor microenvironment of an individual tumor sample. The research team ...
Remestemcel-L (Ryoncil) is an allogeneic bone marrow‒derived mesenchymal stromal cell therapy for steroid-refractory acute graft-vs-host disease in pediatric patients as young as 2 months.
Ryoncil is supplied as a target 25×10 6 MSCs/3.8mL cell suspension in a single-use cryovial packaged in cartons containing 1 and 4 vial (s).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results